E. S. Johnson

1.2k total citations
31 papers, 915 citations indexed

About

E. S. Johnson is a scholar working on Reproductive Medicine, Physiology and Molecular Biology. According to data from OpenAlex, E. S. Johnson has authored 31 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 5 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in E. S. Johnson's work include Hypothalamic control of reproductive hormones (6 papers), Respiratory and Cough-Related Research (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). E. S. Johnson is often cited by papers focused on Hypothalamic control of reproductive hormones (6 papers), Respiratory and Cough-Related Research (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). E. S. Johnson collaborates with scholars based in United States, United Kingdom and Canada. E. S. Johnson's co-authors include R. H. Rippel, Nakul Kadam, Wilfrid F. White, Peter J. Hylands, W. F. White, Eugene R. DeSombre, William F. White, Mattias Hedlund, Gunthard Weber and John F. Wilber and has published in prestigious journals such as Science, The Lancet and JNCI Journal of the National Cancer Institute.

In The Last Decade

E. S. Johnson

30 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. S. Johnson United States	17	240	207	177	116	80	31	915
Fiorella Miceli Italy	21	378 1.6×	234 1.1×	214 1.2×	103 0.9×	11 0.1×	33	1.1k
Chumpol Pholpramool Thailand	16	376 1.6×	239 1.2×	84 0.5×	110 0.9×	22 0.3×	49	807
A.L. Gimeno Argentina	21	218 0.9×	302 1.5×	142 0.8×	383 3.3×	31 0.4×	146	1.7k
Marı́a Laura Barreiro Arcos Argentina	16	100 0.4×	253 1.2×	276 1.6×	52 0.4×	65 0.8×	37	902
M.F. Gimeno Argentina	20	234 1.0×	196 0.9×	108 0.6×	290 2.5×	21 0.3×	100	1.3k
Lindi Luo United States	14	378 1.6×	224 1.1×	315 1.8×	120 1.0×	13 0.2×	17	819
Balwant S. Ahluwalia United States	17	179 0.7×	225 1.1×	172 1.0×	109 0.9×	19 0.2×	53	847
A. D. Mooradian United States	15	127 0.5×	373 1.8×	662 3.7×	215 1.9×	40 0.5×	27	1.4k
James Knudsen United States	15	116 0.5×	123 0.6×	89 0.5×	71 0.6×	64 0.8×	30	543
A. Häusler Switzerland	17	494 2.1×	222 1.1×	269 1.5×	382 3.3×	16 0.2×	24	1.2k

Countries citing papers authored by E. S. Johnson

Since Specialization

Citations

This map shows the geographic impact of E. S. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. S. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. S. Johnson more than expected).

Fields of papers citing papers by E. S. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. S. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. S. Johnson. The network helps show where E. S. Johnson may publish in the future.

Co-authorship network of co-authors of E. S. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of E. S. Johnson. A scholar is included among the top collaborators of E. S. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. S. Johnson. E. S. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnson, E. S., et al.. (2024). Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review. Journal of Clinical Apheresis. 39(6). e22153–e22153.

Johnson, E. S., et al.. (2007). Demyelinating butterfly pseudo-glioma. Journal of Neurology Neurosurgery & Psychiatry. 79(1). 12–13. 4 indexed citations

Haviv, Fortuna, Eugene N. Bush, Gilbert Diaz, et al.. (1994). In vitro and in vivo Activities of Reduced-Size Antagonists of Luteinizing Hormone-Releasing Hormone. Journal of Medicinal Chemistry. 37(5). 701–705. 6 indexed citations

Adjei, Akwete, Sharon Love, E. S. Johnson, et al.. (1993). Effect of Formulation Adjuvants on Gastrointestinal Absorption of Leuprolide Acetate. Journal of drug targeting. 1(3). 251–258. 16 indexed citations

Johnson, E. S.. (1993). Important aspects of the evidence for TCDD carcinogenicity in man.. Environmental Health Perspectives. 99. 383–390. 17 indexed citations

Haviv, Fortuna, Eugene N. Bush, Gilbert Diaz, et al.. (1989). Active reduced-size hexapeptide analogs of luteinizing hormone-releasing hormone. Journal of Medicinal Chemistry. 32(10). 2340–2344. 12 indexed citations

Cork, Linda C., Juan C. Troncoso, E. S. Johnson, et al.. (1988). Neurofilamentous Abnormalities in Motor Neurons in Spontaneously Occurring Animal Disorders. Journal of Neuropathology & Experimental Neurology. 47(4). 420–431. 44 indexed citations

Reinhardt, Dirk, et al.. (1987). Steady State Pharmacokinetics, Metabolism and Pharmacodynamics of Theophylline in Children After Unequal Twice-Daily Dosing of a New Sustained-Release Formulation. Chronobiology International. 4(3). 369–380. 6 indexed citations

Steinijans, V W, et al.. (1987). Theophylline Steady-State Pharmacokinetics: Recent Concepts and Their Application in Chronotherapy of Reactive Airway Diseases. Chronobiology International. 4(3). 331–347. 20 indexed citations

10.

Johnson, E. S., et al.. (1987). Review of the experience with nabumetone in clinical trials outside of the United States. The American Journal of Medicine. 83(4). 110–114. 10 indexed citations

11.

Johnson, E. S., et al.. (1985). Efficacy of feverfew as prophylactic treatment of migraine.. BMJ. 291(6495). 569–573. 193 indexed citations

12.

Rousseaux, Colin G., et al.. (1985). “Shaker” Calf Syndrome: A Newly Recognized Inherited Neurodegenerative Disorder of Horned Hereford Calves. Veterinary Pathology. 22(2). 104–111. 25 indexed citations

13.

Johnson, E. S., et al.. (1976). Delay of Puberty and Inhibition of Reproductive Processes in the rat by a Gonadotropin-Releasing Hormone Agonist Analog. Fertility and Sterility. 27(7). 853–860. 85 indexed citations

14.

DeSombre, Eugene R., E. S. Johnson, & Wilfrid F. White. (1976). Regression of rat mammary tumors effected by a gonadoliberin analog.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(10). 3830–3. 59 indexed citations

15.

Johnson, E. S., et al.. (1976). Endocrine-Dependent Rat Mammary Tumor Regression: Use of a Gonadotropin Releasing Hormone Analog. Science. 194(4262). 329–330. 50 indexed citations

16.

Rippel, R. H. & E. S. Johnson. (1976). Inhibition of HCG-Induced Ovarian and Uterine Weight Augmentation in the Immature Rat by Analogs of GnRH. Experimental Biology and Medicine. 152(3). 432–436. 83 indexed citations

17.

Rippel, R. H., et al.. (1974). Response of the Ewe to Synthetic Gonadotropin Releasing Hormone. Journal of Animal Science. 38(3). 605–612. 26 indexed citations

18.

Rippel, R. H., E. S. Johnson, W. F. White, et al.. (1973). Ovulating and LH-Releasing Activity of a Highly Potent Analog of Synthetic Gonadotropin-Releasing Hormone1. Endocrinology. 93(6). 1449–1452. 17 indexed citations

19.

Rippel, R. H., E. S. Johnson, & W. F. White. (1973). Ovulation and Serum Luteinizing Hormone in the Cycling Rat Following Administration of Gonadotropin Releasing Hormone. Experimental Biology and Medicine. 143(1). 55–58. 10 indexed citations

20.

Johnson, E. S.. (1971). The Homosexual in Prison. Social Theory and Practice. 1(4). 83–95. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact